Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?

Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.

March Jobs Report: How to Interpret and Trade the Latest Numbers

From the Fed's perspective, wage growth doesn't matter anymore.

Nike vs. V.F. Corp.: Two Dividend Growth Stocks Head-to-Head

Picking between the stocks of two industry leaders can be tough, as is the case with Nike and V.F. Corp.

Positioning Ahead of the Trade Deal: Two Areas I Like, One I Don't

The potential U.S.-China trade deal remains the single biggest event facing the market.

SpartanNash: Healthier Foods, Healthier Dividend Yield

Grocery distributor SpartanNash is out front in the trend towards healthier food and beverage products, plus it has an enviable dividend yield.

Treasury Futures' Bearish Specs Finally Have Been Squeezed Out

Although the short squeeze wasn't as quick and swift as we thought it might be, it didn't disappoint in the end.

Why the 10-Year Treasury Bond Price May Have Peaked

The yield has been in a downward trend since early November of last year as price has increased.

Fed at Center of Yield Curve Inversion and Falling Rates

When you hear someone say that a curve inversion 'predicts' a recession, what it really means is that bond traders are 'predicting' a Fed rate cut.

When 3-Month and 10-Year Yields Invert, How Should Investors React?

This yield curve inversion has been a useful leading indicator of a recession, but what really matters is whether it is a signal we can profit from.

Try on This 'Would-Be' Dividend Aristocrat for Its Yield

If it weren't for its smaller market cap, this footwear company would be on the list of Dividend Aristocrats.